Calamos Wealth Management LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 31 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Calamos Wealth Management LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$138,000
+30.2%
106,000
+32.5%
0.02%
+30.8%
Q2 2018$106,000
+11.6%
80,0000.0%0.01%
+8.3%
Q1 2018$95,000
+1.1%
80,0000.0%0.01%0.0%
Q4 2017$94,000
+2.2%
80,000
+3.9%
0.01%
-7.7%
Q3 2017$92,000
-42.1%
77,000
-34.7%
0.01%
-40.9%
Q2 2017$159,000
+7.4%
118,0000.0%0.02%0.0%
Q1 2017$148,000
-3.9%
118,000
-11.9%
0.02%
-12.0%
Q4 2016$154,000
-7.8%
134,000
-3.6%
0.02%
-13.8%
Q3 2016$167,000
+19.3%
139,000
+3.0%
0.03%
+16.0%
Q2 2016$140,000135,0000.02%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
K2 PRINCIPAL FUND, L.P. 9,000$9,953,0000.83%
CSS LLC/IL 10,119,000$11,031,0000.46%
DeepCurrents Investment Group LLC 13,556,000$14,917,0000.45%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$11,014,0000.24%
WOLVERINE ASSET MANAGEMENT LLC 28,592,000$31,218,0000.24%
HBK INVESTMENTS L P 14,616,000$15,971,0000.06%
PALISADE CAPITAL MANAGEMENT, LP 2,127,000$2,334,0000.05%
Verition Fund Management LLC 3,942,000$4,304,0000.04%
LAZARD ASSET MANAGEMENT LLC 10,037,000$10,959,0000.01%
Calamos Advisors LLC 2,423,000$2,648,0000.01%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders